Company / Net Income
Cartesian Therapeutics, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$77.4M
FY2025
5-year range
-$219.7M / -$25.7M
FY2021-FY2025
Trend
+64.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has fluctuated over the past 8 years, ranging from -$220M in FY2024 to -$13M in FY2016.
Based on SEC 10-K filings.
-$77M in FY2025.
Declined from -$26M to -$77M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 64.8% year-over-year.
- Peak net income was recorded in FY2016.
- Lowest net income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$77.4M | +64.8% |
| FY2024 | -$219.7M | -755.3% |
| FY2023 | -$25.7M | +62.7% |
| FY2022 | -$68.9M | -24.4% |
| FY2021 | -$55.4M | +15.3% |
| FY2020 | -$65.3M | -0.0% |
| FY2019 | -$65.3M | -407.2% |
| FY2016 | -$12.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026